Anhydroicaritin(AHI), derived from traditional Chinese medicine, has been shown in vitro to effectively inhibit the PI3K/AKT pathway, suppressing HCC cell proliferation and metastasis (87). Here, AKT1 is linked to hepatocellular carcinoma.